Simplex Trading’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-55
Closed -$16K 9693
2022
Q4
$16K Hold
55
﹤0.01% 7085
2022
Q3
$19K Buy
55
+39
+244% +$18.1K ﹤0.01% 7578
2022
Q2
$7K Buy
+16
New +$8.86K ﹤0.01% 8599
2022
Q1
Sell
-52
Closed -$64K 11002
2021
Q4
$64K Buy
52
+12
+30% +$19.4K ﹤0.01% 6896
2021
Q3
$100K Hold
40
﹤0.01% 6621
2021
Q2
$99K Buy
+40
New +$98K ﹤0.01% 6742
2021
Q1
Hold
0
7795
2020
Q4
Hold
0
6205
2020
Q3
Hold
0
5048
2020
Q2
Hold
0
7380
2020
Q1
Hold
0
-$22K 7980
2019
Q4
Hold
0
5874
2019
Q3
Hold
0
7048
2019
Q2
Hold
0
6880

Other funds holding MBIO

Simplex Trading's MBIO Position: Q2 2023 in Review

Simplex Trading held its Mustang Bio (MBIO) position steady in Q2 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #9535.

Simplex Trading first reported a position in MBIO in Q2 2019 and has held it in 10 quarters since. The position peaked at $155K in Q4 2020. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

  • Simplex Trading held 0 shares of Mustang Bio worth $0 as of Q2 2023.
  • Simplex Trading left its Mustang Bio share count unchanged in Q2 2023.
  • Mustang Bio made up ﹤0.01% of Simplex Trading's portfolio in Q2 2023, its #9535 holding.
  • Simplex Trading first reported a position in Mustang Bio in Q2 2019 and has held it in 10 quarters since.
  • Simplex Trading's Mustang Bio position peaked at $155K in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.